Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 Administered in Healthy Adolescents.				Phase IV				106636 NCT00534638
	Evaluate Safety of a Vaccine Against Cervical Cancer (HPV-16/18 L1/AS04) in Healthy Filipino Females Aged 10 Yrs & Above				Phase IV				108160 NCT00730847
	Diindolylmethane in Treating Patients With Abnormal Cervical Cells				Phase III				CRUK-CRISP-1 ISRCTN47437431, EU-20717, NCT00462813
	Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.				Phase III				106069 NCT00481767
	An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects				Phase III				2007_021 V501-030, NCT00496626
	Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine co-Administered With Another Vaccine in Healthy Female Subjects				Phase III				111507 NCT00652938
	Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in HIV Infected Females				Phase II, Phase I				107863 NCT00586339
	Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia				Phase II				GOG-0207 NCT00081263, GOG-0207
	Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia				Phase II				UARIZ-UAZ03-1-02 UARIZ-HSC-0540, UAZ03-1-02, NCT00303823
	Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women				Phase II				2007_538 V503-001, NCT00543543


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute